Source
From SEC EDGAR
179 releases originally issued via SEC EDGAR. The issuing organizations are responsible for their content.
First Tracks Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Announced ANB033 achieved a statistically significant and clinically meaningful protective effect on both gluten-induced intestinal damage and…
BlueLinx Announces Third Quarter 2026 Results
WEYCO REPORTS THIRD QUARTER 2026 SALES AND EARNINGS;
DECLARES SPECIAL CASH DIVIDEND OF $2.00 PER SHARE
FINANCE OF AMERICA REPORTS THIRD QUARTER 2026 RESULTS
– Funded volume of $748 million increased 24% for the quarter compared to prior year –
Duolingo Reports Third Quarter 2026 Results
SKYWORKS SOLUTIONS, INC.
Skyworks Begins New Chapter Following Qorvo Combination; Reports Fourth Quarter and Fiscal 2026 Results
Ardelyx Reports Third Quarter 2026 Financial Results and Provides Business Update
Q3 2026 total product revenue of $125.5 million, reflecting 19% growth year-over-year
CONTINEUM THERAPEUTICS REPORTS THIRD-QUARTER 2026 FINANCIAL RESULTS
KNIFE RIVER CORPORATION REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
•Revenue increased 6% year-over-year, driven by more asphalt paving and aggregate demand
ADTRAN Holdings, Inc. reports third quarter 2026 financial results
SYSCO REPORTS FIRST QUARTER 2027 RESULTS;
REITERATES FY27 ADJUSTED EPS AND LOCAL VOLUME GUIDANCE
Dynatrace Reports Second Quarter Fiscal Year 2027 Financial Results
ARR grew 16% year-over-year to $2.21 billion
Nuveen Churchill Direct Lending Corp. Announces
Third Quarter 2026 Results
Arvinas Reports Third Quarter 2026 Financial Results and Provides Corporate Update
– Initiated dosing in a Phase 1/2 trial of ARV-6723, an immuno-oncology oral PROTAC designed to degrade HPK1, a negative regulator of immune…